HER2
HER2 is a member of the epidermal growth factor. It initiates the EGF downstream cascade by forming a heterodimer with other ligand-bound EGF receptor. It is associated with breast and ovarian cancers.
Products for HER2
- Cat.No. Product Name Information
-
GC13257
AC480 (BMS-599626)
BMS-599626
AC480 (BMS-599626) (AC480) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC50s of 20 and 30 nM, respectively. AC480 (BMS-599626) displays ~8-fold less potent to HER4 (IC50=190 nM), >100-fold to VEGFR2, c-Kit, Lck, MEK. AC480 (BMS-599626) inhibits tumor cell proliferation, and has potential to increase tumor response to radiotherapy. -
GC10707
Afatinib dimaleate
Afatinib dimaleate, BIBW 2992, BIBW 2992MA2
An inhibitor of EGFR and ErbB2 -
GC10606
BMS-599626 Hydrochloride
AC480;BMS-599626 HCl;BMS599626;BMS 599626;AC-480
-
GC12087
Canertinib dihydrochloride
CI-1033, PD 183805
A pan-ErbB tyrosine kinase inhibitor -
GC13091
CP-724714
HER2 inhibitor,potent and selective
-
GC16008
CUDC-101
A multi-target inhibitor of HDACs, EGFR, and HER2
-
GC10250
Mubritinib (TAK 165)
TAK-165
Mubritinib (TAK 165) (TAK-165) is a potent and selective EGFR2/HER2 inhibitor with an IC50 of 6 nM. -
GC10362
Neratinib (HKI-272)
HKI-272;HKI272;HKI 272
Neratinib (HKI-272) (HKI-272) is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively. -
GC17473
Pelitinib (EKB-569)
EKB569
Pelitinib (EKB-569) (EKB-569;WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively. -
GC17916
Poziotinib
HM781-36B
A irreversible pan-HER inhibitor -
GC11172
TAK-285
HER2/EGFR(HER1) inhibitor
-
GC15271
Tyrphostin AG 879
Tyrphostin AG879
HER2 inhibitor